Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Hironobu Shirataki"'
There are few reports of the adoption of continuous processes in bioproduction, particularly the implementation of end-to-end continuous processes, due to difficulties such as feed adjustment, production batch demarcation, and incorporating virus fil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56d8bca382cdbe5eeece029d5d632492
https://doi.org/10.22541/au.167725626.68946264/v1
https://doi.org/10.22541/au.167725626.68946264/v1
Publikováno v:
Biochemical Engineering Journal. 194:108903
Virus filtration is a critical process in the production of biotherapeutics and drug products derived by plasma fractionation. The processing steps upstream of virus removal filtration impact the filterability (throughput and flux) of process solutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d7324d259dcd58e83a826613d821c8
https://doi.org/10.22541/au.164864304.41227985/v1
https://doi.org/10.22541/au.164864304.41227985/v1
Publikováno v:
SSRN Electronic Journal.
Autor:
Hironobu Shirataki
Publikováno v:
Biochemical Engineering Journal. 183:108460
Publikováno v:
Biotechnology and Bioengineering
We evaluated filtration behavior and virus removal capability for a monoclonal antibodies (mAb) and plasma IgG under constant flow rate directly following flow‐through column chromatography in an integrated process. mAb solution with quantified hos
Virus filtration is a critical process in the production of biotherapeutics and drug products derived by plasma fractionation. The filterability of process solutions on virus removal filters is largely dependent on preceding downstream process steps,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0df55189f7b340dfa5fd728fef028a83
https://doi.org/10.22541/au.160097812.28229702
https://doi.org/10.22541/au.160097812.28229702
We evaluated filtration behavior and virus removal capability for a mAb and plasma IgG under constant flow rate directly following flow-through column chromatography in an integrated process. For mAb solution with quantified host cell protein (HCP) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e48e5b1a18c5778bfd2a42f5fe20a525
https://doi.org/10.22541/au.160093099.97168324
https://doi.org/10.22541/au.160093099.97168324
Autor:
Hironobu Shirataki
Publikováno v:
MEMBRANE. 39:264-267